Can mindfulness tame diabetes distress and blood sugar?
NCT ID NCT07779044
The trial has finished. Results may not be published yet.
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This trial tests whether a 14-week mindfulness-based cognitive behavioral program can improve quality of life and blood sugar control in adults with type 1 or type 2 diabetes. Participants will be randomly assigned to either the program or routine diabetes care. The study measures changes in quality of life and HbA1c levels to see if the program offers added benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A structured mindfulness-based cognitive behavioral program delivered over 14 weekly sessions
- What this could lead to
- If effective, this program could offer a non-drug way to help people with diabetes improve their emotional well-being and better manage blood sugar levels.
- What could go wrong
- This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The program requires significant time commitment, and benefits may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Jan 2026
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18-70 years. * Diagnosis of type 1 or type 2 diabetes mellitus. * Baseline HbA1c level greater than 6.5%. * Mild to moderate depressive symptoms according to the Beck Depression - -Inventory (BDI). * Ability to understand the study procedures and intervention instructions. * Willingness to participate in all intervention sessions. * Ability and willingness to provide written informed consent. Exclusion Criteria: * Severe psychiatric disorders requiring specialized psychiatric care. * Acute medical conditions that could prevent participation in the intervention. * Receiving regular psychotherapy or another similar psychological intervention. * Inability to understand the intervention instructions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSIVE SYMPTOMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Strategic Studies and Health Training
Damascus, Damascus Governorate, Syria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cooking up better diabetes control: can virtual classes teach teens healthier habits?
- Could a Home-Based exercise and relaxation program tame diabetes and Post-COVID stress?
- Can a stomach muscle cut tame diabetes blood sugar?
- Ancient herbal mix may shield blood vessels in diabetes
- Can an mRNA vaccine shield the most vulnerable from RSV?
- Can targeted exercise help older diabetics stay steady on their feet?